Who
Russell Clayton
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Larimar Therapeutics; Senior VP, R&D, Windtree Therapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 7 Oct 2011
- Last trade
- 26 Jan 2026
- Last filed
- 27 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jan 2026filed 27 Jan 2026 | LRMR Larimar TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,637 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | LRMR Larimar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —153,822 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | LRMR Larimar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —153,822 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | LRMR Larimar TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,637 at $0.00 | filing |
| 22 Jan 2025filed 24 Jan 2025 | LRMR Larimar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —139,838 at $0.00 | filing |
| 22 Jan 2025filed 24 Jan 2025 | LRMR Larimar TherapeuticsBiotechnology | SEC FORM 4 Code A | —23,306 at $0.00 | filing |
| 17 Jan 2024filed 19 Jan 2024 | LRMR Larimar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 17 Jan 2024filed 19 Jan 2024 | LRMR Larimar TherapeuticsBiotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 17 Jul 2023filed 18 Jul 2023 | LRMR Larimar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 6 Mar 2014filed 10 Mar 2014 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 6 Mar 2014filed 10 Mar 2014 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 31 Dec 2013filed 12 Feb 2014 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,3751,962 at $2.23 | filing |
| 30 Sep 2013filed 12 Feb 2014 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,3732,528 at $1.73 | filing |
| 30 Jun 2013filed 12 Feb 2014 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,3762,879 at $1.52 | filing |
| 31 Mar 2013filed 12 Feb 2014 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,3741,910 at $2.29 | filing |
| 26 Mar 2013filed 28 Mar 2013 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,124 at $0.00 | filing |
| 26 Mar 2013filed 28 Mar 2013 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,876 at $0.00 | filing |
| 31 Dec 2012filed 13 Feb 2013 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,2522,015 at $2.11 | filing |
| 30 Sep 2012filed 13 Feb 2013 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,2491,496 at $2.84 | filing |
| 30 Jun 2012filed 13 Feb 2013 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,2501,832 at $2.32 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.